The largest database of trusted experimental protocols

13 protocols using tenascin c

1

Histological and Immunohistochemical Analysis of Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor fragments were harvested and immediately fixed in 10% buffered neutral formalin for 24 h at room temperature, then dehydrated and paraffin-embedded. Five-μm sections were subjected to H&E staining and IHC using antibodies against P-Src Y416 (Cell Signaling), Tenascin C (Sigma-Aldrich), and Collagen II (Abcam). Trichrome staining (Sigma-Aldrich) was performed according to the manufacturer's instructions. Picrosirius red staining was performed by the Vanderbilt Translational Pathology Shared Resource. Images were captured using Olympus DP2 software on an Olympus light microscope. Quantification of histochemistry and IHC is described in Supplementary Materials and Methods.
+ Open protocol
+ Expand
2

Tumor Cell Secretome Proteomic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conditioned media from tumor cells was collected and protein was concentrated using 3-kDa cutoff Amicon Ultra Centrifugal Filter Units (Fisher). Protein concentration was measured using the DC Protein Assay (Bio-Rad). Western blot analysis was performed using the Bio-Rad Mini-PROTEAN Tetra System. See reference for TNC western blot protocol [7] (link). Antibodies were obtained from the following sources: pSrc (Tyr418 Cat # 44-660G Invitrogen/Thermo Fisher, Waltham, MA), Src (Cat # 710449 Thermo, Rockford, IL), vinculin (Cat # 6896 R&D, Minneapolis, MN) and tenascin C (Cat # T2551 Sigma Aldrich). Density of all protein of interest bands were normalized to either vinculin or total protein and fold change relative to vehicle or control was determined and is displayed under each western blot.
+ Open protocol
+ Expand
3

Protein Extraction and Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in 150 mM NaCl, 20 mM Tris-HCl pH 7.5, 0.5% NP-40, 2 mM EDTA, 1 mM NaF and protease inhibitors. Primary antibodies used were: Tenascin-C (1:100, Sigma), Galectin-3 (1:100, abcam), CD9 (1:100, Millipore), and GAPDH (1:1000, GeneTex).
+ Open protocol
+ Expand
4

Trans-well Assay for HREC Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the effect of tenascin-C on the migration of HRECs, trans-well assays were performed using 8-µm pore-size cell culture inserts (Corning, Corning, NY). The lower surface of the inserts was coated with tenascin-C or fibronectin (F2006; Sigma-Aldrich, St. Louis, MO) or bovine serum albumin (BSA; 2 µg/insert each). HRECs were suspended at 8 × 105 cells/ml in CSC with 0.5% FBS on the upper surface of the inserts. The cells were allowed to migrate to the lower surface of the membrane for 5 h at 37 °C. The inserts were fixed with 4% paraformaldehyde in PBS and stained with Hoechst 33342 (H3570, 1:1000 dilution; Life Technologies) for 15 min. The stained cells in four random fields were counted under a 20X objective lens, and the data were analyzed with ImageJ software (National Institutes of Health, Bethesda, MD).
+ Open protocol
+ Expand
5

Cell Adhesion on Extracellular Matrix

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-tissue culture-treated 96-well plates were coated with 100 μl of the following matrices in triplicate at given concentrations: Fibronectin at 1 μg/ml, rat tail Collagen-I (BD Biosciences, Franklin Lakes, NJ, USA, 354236) at 0.5 μg/ml, Matrigel at 0.5 μg/ml, Tenascin-C (EMD Millipore, CC 065) at 3 μg/ml, Laminin-I at 10 μg/ml, Collagen-IV at 10 μg/ml and latency-associated peptide (LAP) (Sigma-Aldrich, L3408) at 0.5 μg/ml. Three wells of each plate were coated with 0.1% bovine serum albumin (BSA, PAA Laboratories, K45-001) in phosphate-buffered saline (PBS) (w/v) as a control. Coated plates were incubated for 1 hour at 37 °C after which wells were washed twice with 100 μl PBS per well.
Modified β6-1089 or N-1089 cells were serum starved for 24 hours prior to the experiment. 3 × 103 cells were seeded in 100 μl of serum-free Ham’s F12 per well and allowed to adhere for 1 hour at 37 °C. Then 0.25 μl of Calcein AM (Invitrogen, C1430) cell tracker was added and incubated for 15 minutes at 37 °C after which the plate was washed twice with 100 μl PBS per well, and 100 μl of SFM was added. The plate was read at 490/520 nm on a fluorescent reader (BMG Labtech, Aylesbury, UK, FLUOstar Optima). The adhesion was calculated as the fluorescence value of adherent cells and normalised to that of control cells.
+ Open protocol
+ Expand
6

Detailed Stem Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For all cell culture, α-MEM [15-012-CV] was obtained from Mediatech (Manassas, VA), FBS [S11550H] was obtained from Atlanta Biologicals (Flowery Branch, GA), and L-glutamine [25030-081] was obtained from Thermo Fisher/Gibco (Grand Island, NE). CM-DiI cell tracker [C7000] used in culture was obtained from Life Technologies (Grand Island, NE), and infrared cell tracker was also obtained from Life Technologies [D12731]. For plate coating, rat tail collagen I [354236] was obtained from BD Bioscience at 4.41 mg/mL concentration and Tenascin C was obtained from EMD Millipore [CC065] at 100 μg/mL. Na2B4O7 for prepolymer solvent was obtained from Sigma [S9640-25G], and AgNO3 and (NH4)2S2O8 for prepolymer catalyst solutions were obtained directly from the polymer manufacturer, CM-Tec (Newark, DE). For plug digestion and cell processing for flow, Liberase TL [0540102001] was obtained from Roche (Indianapolis, IN) and 40 μM filters [352340] for cell filtration were obtained from BD Bioscience.
+ Open protocol
+ Expand
7

ECM Coatings for Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Collagen I (rat tail; Sigma Aldrich) and Collagen IV (from human placenta; Sigma Aldrich) were diluted to 20ug/mL in 0.5M acetic acid, tenascin C (human purified; Millipore) was diluted to 5ug/mL in PBS, fibronectin (from human plasma; Millipore), laminin (mouse purified; Millipore) and hyaluronan (high molecular weight; R&D Systems) were diluted to 20ug/mL in PBS. Diluted coatings were applied to cover wells or flasks for 2h at room temperature, then removed and washed with PBS. PBS was removed and cells were seeded in their appropriate media.
For assays using pairwise ECM combinations, Collagen I and Collagen IV were diluted to 40ug/mL in 0.5M acetic acid, tenascin C was diluted to 10ug/mL in PBS, and other ECM components were diluted to 40ug/mL in PBS. These ECM dilutions were mixed 1:1 for each pairwise combination prior to plating. Additional concentration-matched single ECM controls were generated by further diluting single ECM components 1:1 in PBS.
+ Open protocol
+ Expand
8

Tenascin-C Coated Bone Scaffolds for Cell Adhesion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nukbone ® (Biocriss S.A. de C.V. Mexico) bovine trabecular bone scaffolds, in either 200–500 μm particles or 0.5 cm cube were coated with human, full length tenascin-C (Millipore Cat. No. CC06) or BSA control, by immersion of the bone fragments into a 100 μg/ml solution of either protein for seven days. Coating was confirmed by immunohistochemistry (Supplemental experimental procedures). For in vitro adhesion and proliferation experiments, coated NukBone ® cubes were cultured with 250,000 VCaP cells in DMEM/F-12 1:1 (Invitrogen) containing 0.1% BSA, without antibiotics, using non-adhesive (CM) inserts as described before.
+ Open protocol
+ Expand
9

Extracellular Matrix Coating for ASM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue culture plates were incubated overnight with a 10 µg/ml solution of collagen-I (Sigma-Aldrich, #C7774), collagen-IV (Sigma-Aldrich, #C6746), fibronectin (Sigma-Aldrich, #F0895), laminin (Sigma-Aldrich, #L6274) or tenascin-C (#CC065, Millipore). Wells were washed with PBS, blocked with 1% BSA/PBS and again washed with PBS as previously described [14] (link). For cell derived ECM preparations, ASM cells from control and asthma derived cells were cultured in 12-well culture plates for 14 days, media aspirated and cells removed using ammonium hydroxide (50 mM) and Triton X-100 (0.05%). Following incubation with DNase I (20 U/ml) plates were washed with PBS and stored overnight (4°C). This preparation results in a cell free bioactive ECM coating [29] (link). Plates were allowed to warm to room temperature prior to seeding serum starved ASM cells, and cell culture supernatants were harvested after 24 hours.
+ Open protocol
+ Expand
10

Transfection-based Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection complexes were formed combining 30 nM single siRNA or 15 nM each of combined siRNAs with 10 μl Dharmafect 1 or 2 and OPTI-MEM in a total volume of 400 μl. After a 20-minute incubation, 1.6 ml antibiotic-free media containing 10% FBS was mixed in and the total volume added to cells at 50% confluence on 60 mm plates. After 5 hours of incubation at 37°C/5% carbon dioxide, an additional 2 ml complete media were added to each plate. Next day, the cells were trypsinized and cells were plated (8,000 cells for MDA-MB-231 and SUM-149; 10,000 cells for MCF-7LTamR) into four wells per transfection condition in Primaria 96-well plates coated with 0.33 mg/ml Matrigel (354234; BD Biosciences), 0.2 μg/ml tenascin-C (CC065; Millipore Billerica, MA, USA) and 0.1 μg/ml fibronectin (F-0895; Sigma). Ninety-six hours following transfection initiation, CellTiter 96® Aqueous One Assays were performed according to the manufacturer’s instructions (Madison, WI, USA). Absorbance values for media alone were subtracted from the experimental values. The data shown represent the results of five experiments for MDA-MB-231, of four experiments for SUM-149, and of two experiments for MCF-7TamR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!